This 1997 image was created during a investigation into an outbreak of monkeypox, which took place in the Democratic Republic of Congo (DRC), 1996 to 1997, formerly Zaire, and depicts the palms of a monkeypox case patient from Lodja, a city located within the Katako-Kombe Health Zone, of the DRC. (CDC via Bay City News)

People who are at high risk for monkeypox can now get vaccinated for the virus via intradermal injection after the U.S. Food and Drug Administration authorized the technique.

The FDA issued an emergency use authorization Tuesday for intradermal administration of the two-dose Jynneos vaccine for smallpox and monkeypox.

Continue reading for free

Sign in to read this story and receive the weekly roundup in your inbox.

Or

Terms & Conditions

Success! Your account was created and you’re signed in.
Please visit My Account to manage your account.

Eli covers public health, transportation and state politics for the Bay City News Foundation, serves as the main editor of the Public Health and COVID-19 Information Hub and assists with Local News Matters' social media strategy. He has also previously covered local politics in San Diego County as well as college and professional sports across the Bay Area.